MFG Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.93M Buy
30,984
+11,538
+59% +$729K 1.4% 37
2026
Q2
$1.12M Sell
19,446
-126
-0.6% -$7.24K 0.8% 59
2026
Q1
$1.19M Sell
19,572
-584
-3% -$34K 0.98% 55
2025
Q4
$1.09M Buy
+20,156
New +$970K 0.85% 52
2025
Q1
– Sell
-30,397
Closed -$1.72M – 60
2024
Q4
$1.72M Buy
+30,397
New +$1.7M 1.58% 32

Other funds holding BMY

MFG Wealth Management's BMY Position: Q3 2026 in Review

MFG Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 59% in Q3 2026, buying an estimated $729K and bringing the position to 30,984 shares worth $1.93M. The position accounts for 1.4% of the portfolio, ranked #37.

MFG Wealth Management first reported a position in BMY in Q4 2024 and has held it in 5 quarters since. 907 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • MFG Wealth Management held 30,984 shares of Bristol-Myers Squibb worth $1.93M as of Q3 2026.
  • MFG Wealth Management bought 11,538 Bristol-Myers Squibb shares in Q3 2026, an estimated $729K.
  • Bristol-Myers Squibb made up 1.4% of MFG Wealth Management's portfolio in Q3 2026, its #37 holding.
  • MFG Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 5 quarters since.
  • 907 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on MFG Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.